Trending News

Monkeypox virus
#Antivirals #DNA mutations #Immunology / Virology & Vaccines #Monkeypox #Monkeypox vaccine #Virus mutation

Researchers reveal how monkeypox evolves to evade drugs 

A team of scientists has identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness. Monkeypox has infected more than 77,000 people in more than 100 countries worldwide. Mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and… Read More

#News #Trending News

Magic mushrooms
#Depression #Mental health #Psilocybin #Psychedelics #The New England Journal of Medicine #Treatment-resistant depression #Trial data

Study shows ‘magic mushrooms’ could treat depression 

Psilocybin, a psychedelic derived from mushrooms, has been proven effective as a therapy for treatment-resistant depression (TRD) in the largest study of its kind.  The results of COMPASS Pathways’ Phase IIb trial have been published in The New England Journal of Medicine (NEJM). Read More

#News #Trending News

Mosquito against yellow background
#Malaria #Monoclonal antibodies #National Institute of Allergy and Infectious Diseases #Phase II trial #Sub-Saharan Africa

Monoclonal antibody could transform malaria prevention

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa.   The antibody was up to 88.2% effective at preventing infection over a 24-week period, demonstrating for the first time that a monoclonal antibody can… Read More

#News #Trending News

Excitatory/inhibitory neuronal reporter
#Gene delivery #Gene expression #Gene therapy #Precision medicine #Proteins

Gene expression delivery tool ‘slides’ instructions into cells

Researchers say they have successfully used a cell’s natural process for making proteins to ‘slide’ genetic instructions into a cell and produce critical proteins missing from those cells.   If further studies verify the results, this could be a new method for targeting specific cell types for a… Read More

#News #Trending News

Covid-19 vaccination
#Covid-19 #Covid-19 vaccine #Immunocompromised #Immunology / Virology & Vaccines

Covid-19 vaccine less effective in the immunocompromised 

A new study in the US has revealed that the Covid-19 vaccine is less effective in people with weakened immune systems.  The research from the Centers for Disease Control and Prevention’s VISION Network analysed real-world data on mRNA vaccine effectiveness during Omicron BA.4 and BA.5 predominance… Read More

#Covid-19 #News #Trending News

Colorectal cancer cells
#Cancer research #Chemotherapy #Chemotherapy-resistance #Colorectal cancer #Oncology #Tyrosine kinase inhibitors

Targeted cancer drug overcomes chemotherapy resistance

A team from the University of Geneva (UNIGE) has found a way to overcome chemotherapy resistance in colorectal cancer.  The team successfully used a combination of tyrosine kinase inhibitors, opening up new avenues for developing therapies that are more targeted than chemotherapy.  Colorectal cancer is… Read More

#Cancer Research #News #Trending News

Our Future Health study
#Genetic study #Health research programme #NHS #Our Future Health #Predictive diagnostics #UK

Millions invited to join UK’s largest health research programme

Over three million people have been invited to join Our Future Health, which is set to become the UK’s largest ever health research programme. Letters are being sent out this autumn inviting members of the public to join Our Future Health, designed to help develop new ways to prevent, detect… Read More

#News #Trending News

Wear it Pink
#Breast cancer #Breast Cancer Now #Cancer research #Chemotherapy #Chemotherapy-resistance #Drug discovery #Oncology #Tumours

Five breakthroughs advancing breast cancer therapies

Not only is October Breast Cancer Awareness Month but October 21 is Wear it Pink 2022, Breast Cancer Now’s annual fundraising day. While advances in treatment over the last few years have resulted in good overall survival rates for patients with non-metastatic disease (90% five-year survival rate in the US1),… Read More

#Cancer Research #News #Trending News

Antibiotics
#Antibiotic resistance #Antibiotics #Bacterial genome #Gram-negative bacteria #Northeastern University #University of Basel

New antibiotic could kill resistant pathogens

An international team of researchers has discovered a new antibiotic by computational analysis and deciphered its mode of action.  The researchers also found that Dynobactin kills Gram-negative bacteria, which include many dangerous and resistant pathogens.  The team were led by researchers from the Northeastern University… Read More

#News #Trending News

RNA vaccine
#Cancer research #Cancer vaccine #Immuno-oncology #Immunology / Virology & Vaccines #Melanoma #Merck #Moderna #mRNA

Merck and Moderna to develop personalised cancer vaccine

Merck (MSD) and Moderna have revealed plans to work together on the development and commercialisation of an investigational personalised cancer vaccine. The companies will report data from the ongoing Phase II trial of mRNA-4157/V940 in combination with KEYTRUDA in high-risk melanoma later this year. “We have been collaborating with Merck… Read More

#Cancer Research #News #Trending News

Cat in a box
#Allergen immunotherapy #Allergy #Monoclonal antibodies

Combination treatment could be more effective for cat allergy

New research has shown that standard cat allergy treatment can be enhanced to make it more effective and faster acting, and the benefits last for a year after treatment ends. These results show for the first time that adding a cytokine inhibitor to allergy shots could reduce allergic rhinitis symptoms… Read More

#News #Trending News

Ice Bucket Challenge
#ALS #Drug discovery #FDA #Fundraising #Ice Bucket Challenge #The ALS Association

‘Ice Bucket Challenge’ funds FDA-approved ALS treatment

The US Food and Drug Administration (FDA) has granted approval to AMX0035, a new treatment for people living with amyotrophic lateral sclerosis (ALS). Development of the drug was funded by $2.2 million from the ALS Association, raised by the 2014 social media craze the ‘Ice Bucket Challenge'. Another 40 potential… Read More

#News #Regulatory #Trending News

Herpes virus cells
#Cancer research #Cancer treatment #Herpes virus #Immunotherapy #Oncology #The Institute of Cancer Research

Researchers successfully exploit virus against advanced cancers

A new genetically engineered herpes virus has delivered a one-two punch against advanced cancers in initial findings from a Phase I trial. Researchers have found that RP2 – a modified version of the herpes simplex virus – showed signs of effectiveness in a quarter of patients with a range of… Read More

#Cancer Research #News #Trending News

Flu virus
#Covid-19 #Flu #Immune response #Influenza #Omicron

Omicron infection likely to protect against flu

The latest Omicron variants of Covid could be protective against serious influenza infection, a leading testing expert says. The milder variants have now made Covid-19 less dangerous than the flu, though there is still the risk of developing long Covid. Dr Quinton Fivelman PhD, Chief Scientific Officer at London Medical… Read More

#Covid-19 #News #Trending News

Covid patient receiving oxygen
#Antivirals #Clinical trial #Covid-19 #Human trials

POC study proves efficacy of zapnometinib in severe Covid-19

A proof of concept (POC) study has shown the clinical benefit of zapnometinib in patients with severe Covid-19 and supports further evaluation in severe viral diseases. Atriva Therapeutics and investigators will continue to evaluate the RESPIRE data and will provide an update on the full dataset in due course. The POC… Read More

#Covid-19 #News #Trending News